Trastuzumab emtansine vs lapatinib and capecitabine in HER2-positive metastatic breast cancer brain metastases: A real-world study

Sanglier, T; Shim, J; Lamarre, N; Peña-Murillo, C; Antao, V; Montemurro, F

Sanglier, T (通讯作者)，F Hoffmann La Roche, Grenzacherstr 124, CH-4070 Basel, Switzerland.

BREAST, 2023; 69 (): 441

Abstract

Background: Trastuzumab emtansine (T-DM1) has demonstrated improvements in survival and neurological symptoms in patients with breast cancer with brai......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索